| Title | Date | PubMed ID |
|---|
| Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating P(k), P1 and NOR blood group antigens. | 2016 Jan 29 | 26773500 |
| Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells. | 2015 Aug 1 | 26004871 |
| A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome. | 2012 Nov 2 | 22965229 |
| Increased globotriaosylceramide levels in a transgenic mouse expressing human alpha1,4-galactosyltransferase and a mouse model for treating Fabry disease. | 2011 Feb | 20961863 |
| Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis. | 2010 Nov 12 | 20837469 |
| A novel, promoter-based, target-specific assay identifies 2-deoxy-D-glucose as an inhibitor of globotriaosylceramide biosynthesis. | 2009 Sep | 19674101 |
| Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression. | 2009 May 31 | 19470247 |
| Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels. | 2009 Jan | 18842961 |
| Identification and characterization of the human Gb3/CD77 synthase gene promoter. | 2008 Dec | 18757779 |
| Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. | 2008 May | 18176841 |